7
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Reducing diazepam prescribing for illicit drug users: A randomised control study

, , , , , & show all
Pages 25-31 | Received 28 Jul 2003, Accepted 30 Mar 2004, Published online: 12 Jul 2009

References

  • Information and Statistics Division, Primary Care Informa-tion Unit. Drugs Misuse Statistics, Scotland. Scottish Executive: Edinburgh, 2000.
  • Hay G, McKeganey N. Estimating the prevalence of drug misuse in Dundee, Scotland: an application of capture-recapture methods. J Epidemiol Commun Health 1996;50:469–72.
  • Ross J, Darke S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction 2000;95,12:1785–93.
  • Oliver P, Keen GR, Mathers N. Deaths from drugs of abuse in Sheffield in 1998: therole of prescribed medication. Br J Gen Practice 2001;51:394–6.
  • Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend 2000;60:141–50.
  • Darke S. Benzodiazepine use among injecting drug users: problems and implications. Addiction 1994;89:379–82.
  • Oliver P, Keen J. Concomitant drugs of misuse and drug using behaviours associated with fatal opiate-related poison-ings in Sheffield, UK, 1997-2000. Addiction 2003;98,2:191–7.
  • Sheedy DL, Garrick TM, Fortis AH, Harper CG. Changing trends in heroin-related deaths in Sydney, Australia-1995-1999. Am J Addictions 2003;12,1:52–9.
  • Department of Health. Drug misuse and dependence: guidelines on clinical management. London: Stationery Office, 1999.
  • Seivewright N. Theory and practice in managing benzodia-zepine dependence and misuse. J Substance Misuse 1998;3:170–7.
  • Mant A, Walsh RA. Reducing benzodiazepine use. Drug Alcohol Rev 1997;16:77–84.
  • Woods H, Winger G. Current benzodiazepine issues. Pharmacology 1995;118:107–15.
  • Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiaze-pine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry 1993;150,10:1485–90.
  • Ashton H. The treatment of benzodiazepine dependence. Addiction 1994;89:153–4.
  • Otto MW, Jones J, Craske M, Barlow DH. Stopping Anxiety Medication: Panic Control Therapy for Benzodia-zepine Discontinuation. New York: Graywind Publications Incorporated, 1996.
  • Otto MW, Pollack MH, Barlow DH. Stopping Anxiety Medication. New York: Greywind Publications Incorpo-rated, 1995.
  • British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 41, 2001.
  • Marsden J, Gossop M, Stewart D, Best D, Farrell M, Strang J. The Maudsley Addiction Profile: A brief instru-ment for treatment outcome research. National Addiction Centre: London, 1998.
  • Moorey S, Greer S, Watson M, Gorman C, Tunmore R. The factor structure and factor stability of the Hospital Anxiety and Depression Scale in patients with cancer. Br J Psychiatry 1991;158:255–9.
  • Buysse D, Reynolds C, Monk T, Berman S, Kupfer D. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
  • Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol 1997;7,8:568–74.
  • Rooney S, Kelly G, Bamford L, Slaon D, O’Conner JJ. Co-abuse of opiates and benzodiazepines. Irish Med J 1999;168,1:36–41.
  • Drake S, Ross J, Cohen J. The use of benzodiazepines among regular amphetamine users. Addiction 1994;89:1683–90.
  • Vorma H, Naukkarinen H, Sarna S, Kuoppasalmi K. Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches. Addiction 2002;97:851–9.
  • Seivewright N. Benzodiazepine misuse by illicit drug misusers. Addiction 2001;96:333–6.
  • Woods JW, Katz J, Winger G. Benzodiazepines: Use, abuse and consequences. Pharmacol Rev 1992;155-323.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.